RxDoctor Payments Data

Vincent Sciulla, DPM

Podiatry · Brooklyn, NYNPI 1952496200

Payments from drug & device makers

What this record shows

Among podiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 90th percentile of 225 podiatry providers in New York.

See all podiatry providers in New York

Medicare billing

Part B allowed, 2024
$572,334
Medicare patients
1,557
Services billed
5,208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.33$13,001
Ketoconazole139$5,086
Ammonium Lactate93$2,381
Clotrimazole59$2,158
Clobetasol Propionate24$1,444
Mupirocin143$888
Cefdinir40$537
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip18$408

Paid to pharmacies, not to this prescriber.

Other podiatry in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →